Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Obeticholic acid or its saltsPDL I MAY / 17
ObinutuzumabPDL I DEC / 14
Oclacitinib or its saltsPDL

including but not limited to Oclacitinib maleate

I AUG / 14
Octatropine methylbromideF1 I SEP / 98
OctreotideF1 I SEP / 98
Ofloxacin and its saltsF1 I SEP / 98
Olanzapine and its saltsF1 I SEP / 99
OlaparibPDL I AUG / 16
Oleandomycin and its salts and derivativesF2 I SEP / 98
Olmesartan and its salts and derivativesF1 I MAR / 11
Olopatadine and its saltsF1 I SEP / 98
Olsalazine and its saltsF1 I SEP / 98
OmalizumabF1 I FEB / 07
OmbitasvirPDL I MAR / 15
Omeprazole or its saltsPDL

including but not limited to omeprazole, omeprazole magnesium except when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole

I SEP / 14
Omeprazole or its salts.

when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of omeprazole

II SEP / 14
Ondansetron and its saltsF1 I SEP / 98
OpiumN I JUN / 02
Orbifloxacin and its salts and derivativesF1 I MAY / 04
OrciprenalineF1 Metaproterenol and its salts I SEP / 98
Ormetoprim and its saltsF1 I SEP / 98
OrnidazoleF1 I SEP / 98
Orphenadrine citrate III SEP / 98
Orphenadrine hydrochloride I SEP / 98
Oseltamivir and its saltsF1 I MAR / 01
Osimertinib or its saltsPDL I AUG / 16
Oxabolone and its derivativesC3 I SEP / 98
OxaliplatinF1 I SEP / 08
OxanamideF1 I SEP / 98
OxandroloneC3 I JUN / 02
Oxaprozin and its salts and derivativesF1 I SEP / 98
Oxazepam and its saltsTS I SEP / 98
OxazolamTS I JUN / 02
OxcarbazepineF1 I DEC / 01
Oxethazine III SEP / 98
Oxiconazole 1% for topical use U SEP / 99
Oxolinic acid and its saltsF1 I SEP / 98
Oxprenolol and its saltsF1 I SEP / 98
Oxybuprocaine and its salts benoxinate for opthalmic or parenteral use II SEP / 98
Oxybuprocaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Oxybutynin and its saltsF1 I SEP / 98
OxycodoneN I JUN / 02
OxymesteroneC3 I JUN / 02
Oxymetazoline in nasal preparations for adult use and in ophthalmic products U
Oxymetazoline and its salts in nasal preparations for pediatric use II SEP / 98
OxymetholoneC3 I JUN / 02
OxymorphoneN I JUN / 02
Oxyphenbutazone and its saltsF1 I SEP / 98
Oxyquinoline II SEP / 98
OxytocinF1 I SEP / 98
Ozenoxacin or its saltsPDL I JUN / 17

51 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled